Richard A. Moscicki, Senior VP, Chief Medical Officer at GENZYME CORP (GENZ), sold 36,635 shares at $76.73 ($2.8M) on 2008-09-23, disclosed to the SEC on 2008-09-25.
Scheduled sale ($2.8M) by Senior VP, Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| GENZ | SELL | 2008-06-27 | $2.6M | — | Filing → |
| GENZ | SELL | 2008-01-22 | $3.8M | — | Filing → |
| GENZ | SELL | 2008-01-10 | $3.6M | — | Filing → |